Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2023 Earnings Call Transcript November 8, 2023
Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $0.00238, expectations were $-0.04.
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Third Quarter 2023 Vanda Pharmaceuticals, Inc. Earnings Conference Call. [Operator Instructions] I would now like to...
